Cristina Jácome1, Alda Marques. 1. Research Centre in Physical Activity, Health and Leisure, Faculty of Sports, University of Porto, Porto, Portugal, and the School of Health Sciences, University of Aveiro, Aveiro, Portugal.
Abstract
BACKGROUND: Pulmonary rehabilitation (PR) is effective in improving exercise capacity and health-related quality of life (HRQOL) in patients with moderate-to-very-severe COPD. Quadriceps strength and HRQOL can be impaired in patients with mild COPD, therefore, patients at this grade may already benefit from PR. However, the impact of PR in patients with mild COPD remains unestablished. Thus, this systematic review assessed the impact of PR on exercise capacity, HRQOL, health-care resource use and lung function in patients with mild COPD. METHODS: The Web of Knowledge, EBSCO, MEDLINE, and SCOPUS databases were searched up to April 2013. Reviewers independently selected studies according to the eligibility criteria. RESULTS: Three studies with different designs (retrospective, one group pretest-posttest, and randomized controlled trial) were included. Out-patient PR programs were implemented in two studies, which included mainly aerobic, strength, and respiratory muscle training. The randomized controlled trial compared a PR home-based program, consisting of 6 months of walking and participating in ball games, with standard medical treatment. Significant improvements in exercise capacity (effect size [ES] 0.87-1.82) and HRQOL (ES 0.24-0.86) were found when comparing pretest-posttest data and when comparing PR with standard medical treatment. In one study, a significant decrease in hospitalization days was found (ES 0.38). No significant effects were observed on the number of emergency department visits (ES 0.32), number of hospitalizations (ES 0.219), or lung function (ES 0.198). CONCLUSIONS: Most of the PR programs had significant positive effects on exercise capacity and HRQOL in patients with mild COPD; however, their effects on health-care resource use and lung function were inconclusive. This systematic review suggests that patients with mild COPD may benefit from PR; however, insufficient evidence is still available. Studies with robust designs and with longer follow-up times should be conducted.
BACKGROUND: Pulmonary rehabilitation (PR) is effective in improving exercise capacity and health-related quality of life (HRQOL) in patients with moderate-to-very-severe COPD. Quadriceps strength and HRQOL can be impaired in patients with mild COPD, therefore, patients at this grade may already benefit from PR. However, the impact of PR in patients with mild COPD remains unestablished. Thus, this systematic review assessed the impact of PR on exercise capacity, HRQOL, health-care resource use and lung function in patients with mild COPD. METHODS: The Web of Knowledge, EBSCO, MEDLINE, and SCOPUS databases were searched up to April 2013. Reviewers independently selected studies according to the eligibility criteria. RESULTS: Three studies with different designs (retrospective, one group pretest-posttest, and randomized controlled trial) were included. Out-patientPR programs were implemented in two studies, which included mainly aerobic, strength, and respiratory muscle training. The randomized controlled trial compared a PR home-based program, consisting of 6 months of walking and participating in ball games, with standard medical treatment. Significant improvements in exercise capacity (effect size [ES] 0.87-1.82) and HRQOL (ES 0.24-0.86) were found when comparing pretest-posttest data and when comparing PR with standard medical treatment. In one study, a significant decrease in hospitalization days was found (ES 0.38). No significant effects were observed on the number of emergency department visits (ES 0.32), number of hospitalizations (ES 0.219), or lung function (ES 0.198). CONCLUSIONS: Most of the PR programs had significant positive effects on exercise capacity and HRQOL in patients with mild COPD; however, their effects on health-care resource use and lung function were inconclusive. This systematic review suggests that patients with mild COPD may benefit from PR; however, insufficient evidence is still available. Studies with robust designs and with longer follow-up times should be conducted.
Authors: Praful Schroff; Jason Hitchcock; Christopher Schumann; J Michael Wells; Mark T Dransfield; Surya P Bhatt Journal: Ann Am Thorac Soc Date: 2017-01
Authors: Pervin Korkmaz Ekren; Alev Gürgün; Funda Elmas Uysal; Şenay Tuncel; Sami Deniz; Hale Karapolat; Feza Bacakoğlu Journal: Turk J Phys Med Rehabil Date: 2018-05-23
Authors: Gracielle Vieira Ramos; Alessandra Choqueta de Toledo-Arruda; Clara Maria Pinheiro-Dardis; Camila Liyoko Suehiro; Thiago Luiz de Russo; Rodolfo Paula Vieira; Milton Arruda Martins; Tania Fátima Salvini; João Luiz Quagliotti Durigan Journal: Biomed Res Int Date: 2018-03-29 Impact factor: 3.411
Authors: Eric W Tsang; Henry Kwok; Aidan K Y Chan; Kah Lin Choo; Kin Sang Chan; Kam Shing Lau; Chetwyn C H Chan Journal: BMC Pulm Med Date: 2018-08-09 Impact factor: 3.317
Authors: Lara Siebeling; Jammbe Z Musoro; Ronald B Geskus; Marco Zoller; Patrick Muggensturm; Anja Frei; Milo A Puhan; Gerben ter Riet Journal: NPJ Prim Care Respir Med Date: 2014-08-28 Impact factor: 2.871